Andrew Saik
2021 - Intercept Pharmaceuticals
Compensation breakdown
Bonus | $102,500 |
---|---|
Non-Equity Incentive Plan | $113,823 |
Option Awards | $903,848 |
Salary | $251,894 |
Stock Awards | $1,086,931 |
Other | $16,857 |
Total | $2,475,854 |
Saik received $1.1M in stock awards, accounting for 44% of the total pay in 2021.
Saik also received $102.5K in bonus, $113.8K in non-equity incentive plan, $903.8K in option awards, $251.9K in salary and $16.9K in other compensation.
Rankings
In 2021, Andrew Saik's compensation ranked 5,186th out of 12,406 executives tracked by ExecPay. In other words, Saik earned more than 58.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,186 | 58th |
Manufacturing | 2,178 | 60th |
Chemicals And Allied Products | 939 | 60th |
Drugs | 839 | 60th |
Pharmaceutical Preparations | 602 | 61st |
Pay ratio
Andrew Saik's Pay | $2,475,854 |
---|---|
Median Employee's Pay | $216,748 |
Pay Ratio | 11to 1 |
In 2021, the annual total compensation of Andrew Saik was $2,475,854.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.
The ratio of Andrew Saik's pay to the pay of median employee was therefore 11 to one.
Saik's colleagues
We found six more compensation records of executives who worked with Andrew Saik at Intercept Pharmaceuticals in 2021.
2021
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
2021
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
2021
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
2021
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
2021
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2021
Rocco Venezia
Intercept Pharmaceuticals